Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03368859
Title A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine/Oxaliplatin and Bevacizumab
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie

colon adenocarcinoma

rectum adenocarcinoma


ABT-165 + Fluorouracil + Irinotecan + Leucovorin

Bevacizumab + Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.